Your browser doesn't support javascript.
loading
Low-Dose Triptolide Enhanced Activity of Idarubicin Against Acute Myeloid Leukemia Stem-like Cells Via Inhibiting DNA Damage Repair Response.
Shi, Pengcheng; Zha, Jie; Feng, Juan; Jiang, Zhiwu; Zhao, Haijun; Deng, Manman; Liao, Naying; Li, Peng; Jiang, Yirong; Song, Haihan; Xu, Bing.
Afiliação
  • Shi P; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
  • Zha J; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, No.55, Zhenhai Road, Xiamen, Fujian, 361003, People's Republic of China.
  • Feng J; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, No.55, Zhenhai Road, Xiamen, Fujian, 361003, People's Republic of China.
  • Jiang Z; Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
  • Zhao H; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, No.55, Zhenhai Road, Xiamen, Fujian, 361003, People's Republic of China.
  • Deng M; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, No.55, Zhenhai Road, Xiamen, Fujian, 361003, People's Republic of China.
  • Liao N; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
  • Li P; Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
  • Jiang Y; Department of Hematology, Affiliated Dongguan People's Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, 523059, People's Republic of China. dgjyr0769@163.com.
  • Song H; Department of Immunology, DICAT Biomedical Computation Centre, Vancouver, BC, Canada. haihansong@126.com.
  • Xu B; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, No.55, Zhenhai Road, Xiamen, Fujian, 361003, People's Republic of China. xubingzhangjian@126.com.
Stem Cell Rev Rep ; 17(2): 616-627, 2021 04.
Article em En | MEDLINE | ID: mdl-33078278
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenantrenos / Células-Tronco Neoplásicas / Dano ao DNA / Idarubicina / Leucemia Mieloide Aguda / Diterpenos / Reparo do DNA Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenantrenos / Células-Tronco Neoplásicas / Dano ao DNA / Idarubicina / Leucemia Mieloide Aguda / Diterpenos / Reparo do DNA Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article